Yunnan Jing

Yunnan Jing

Auto-generated profile, based on publicly available information

Yunnan Jing

Heilongjiang University of Chinese Medicine, Harbin, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2023 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
JLJiawei Liu
Jiawei Liu
SZShuang Zhang
Shuang Zhang
YJYunnan Jing
Yunnan Jing
WZWei Zou
Wei Zou


30 December 2022 in Medicine
Verified
Journal Article
Open access
YJYunnan Mm Jing
Yunnan Mm Jing
SHSiya Mm Hu
Siya Mm Hu
JSJing Mm Song
Jing Mm Song
XDXu Dong
Xu Dong
YZYing Mm Zhang
Ying Mm Zhang
DWDongyan Wang
Dongyan Wang
Background: Atherosclerosis remains a predominant cause of ischemic stroke (IS). Four miRNA polymorphisms associated with arteriosclerosis mechanism were meta-analyzed to explore whether they had predictive significance for IS. Methods: PubMed, Excerpta Medica database, Web of Science, Cochrane Library, Scopus, China National Knowledge Infrastructure, and China Wanfang Database were searched for relevant case-control studies published before September 2022. Two researchers independently reviewed the studies and extracted the data. Data synthesis was carried out on eligible studies. Meta-analysis, subgroup analysis, sensitivity analysis, and publication bias analysis were performed using Stata software 16.0. Results: Twenty-two studies were included, comprising 8879 cases and 12,091 controls. The results indicated that there were no significant associations between miR-146a C>G (rs2910164), miR-196a2 T>C (rs11614913) and IS risk in the overall analyses, but miR-149 T>C (rs2292832) and miR-499 A>G (rs3746444) increased IS risk under the allelic model, homozygote model and recessive model. The subgroup analyses based on Trial of Org 101072 in Acute Stroke Treatment classification indicated that rs2910164 increased small artery occlusion (SAO) risk under the allelic model, heterozygote model and dominant model; rs11614913 decreased the risk of SAO under the allelic model, homozygote model, heterozygote model and dominant model. Conclusion: This Meta-analysis showed that all 4 single nucleotide polymorphisms were associated with the risk of IS or SAO, even though the overall and subgroup analyses were not entirely consistent.

13 July 2026 in Phytotherapy Research
Verified
Journal Article
Closed access
FXFeng Xiang
Feng Xiang
LLLiyue Lu
Liyue Lu
FLFangfei Li
Fangfei Li
YJYunnan Jing
Yunnan Jing
YLYanhua Li
Yanhua Li
JDJiangchuan Dong
Jiangchuan Dong